Control of von Willebrand factor multimer size by thrombospondin-1

Journal of Experimental Medicine

Volumn 193, Issue 12, 2001, Pages 1341-1349

  Xie, Lijuan ^a   Chesterman, Colin N ^a   Hogg, Philip J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Disulfide; Endothelial cell; Hemostasis; Reductase; Thrombosis

Indexed keywords

THROMBOSPONDIN 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD VESSEL INJURY; CASE REPORT; DISULFIDE BOND; FEMALE; HEMOSTASIS; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOGENESIS; THROMBOSIS;

ADULT; AGED; ANIMALS; BINDING SITES; CHILD, PRESCHOOL; CULTURE MEDIA, CONDITIONED; DISULFIDES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MICE; MODELS, BIOLOGICAL; MOLECULAR WEIGHT; OXIDOREDUCTASES; PROTEIN STRUCTURE, TERTIARY; PURPURA, THROMBOTIC THROMBOCYTOPENIC; THROMBOSPONDIN 1; VON WILLEBRAND FACTOR;

EID: 0035908117     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.193.12.1341     Document Type: Article

References (38)

1. Biochemistry and genetics of von Willebrand factor
2. Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor
3. Localization of disulfide bonds in the cysteine knot domain of human von Willebrand factor
4. Topology, and order of formation of interchain disulfide bonds in von Willebrand factor
5. Disulfide bonds required to assemble functional von Willebrand factor multimers
6. Von Willebrand factor: Molecular size and functional activity
7. Studies on factor VIII-related protein. III. Size distribution and carbohydrate content of human and bovine factor VIII
8. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation
9. Studies on the pathophysiology of thrombotic thrombocytopenic purpura
10. Cryosupernatant regulates accumulation of unusually large vWF multimers from endothelial cells
11. Plasma von Willebrand factor processing activity functions like a disulfide bond reductase: Reversible decrease of multimer size
12. Reduction of von Willebrand factor by endothelial cells
13. Factor VIII/von Willebrand factor has potent lectin activity
14. Localization of thrombospondin in clots formed in situ
15. Interaction of platelet-derived growth factor with thrombospondin 1: Dependence on the disulfide-bond arrangement in thrombospondin 1
16. Cultured fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix
17. Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between type I and type II, von Willebrand's disease
18. Variant von Willebrand's disease: Characterization of two subtypes by analysis of multimer composition of factor VIII/von Willebrand factor in plasma and platelets
19. Cleavage of structural proteins during assembly of the head of bacteriophage T4
20. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
21. The determination of von Willebrand factor activity by collagen binding assay
22. Synthesis and secretion of thrombospondin by cultured human endothelial cells
23. The functions of thrombospondin-1 and -2
24. Free thiols of platelet thrombospondin
25. Disulfides modulate RGD-inhibitable cell adhesive activity, of thrombospondin
26. A monoclonal antibody-based enzyme-linked immunosorbent assay for quantitation of plasma thrombospondin
27. Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain
28. Biological activities of peptides and peptide analogues derived from common sequences present in thrombospondin, properdin, and malarial proteins
29. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
30. Quantitative analysis of von Willebrand factor propeptide release in vivo: Effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans
31. Ristocetin-dependent reconstitution of binding of von Willebrand Factor to purified human platelet membrane glycoprotein Ib-IX complex
32. The protein disulfide-isomerase family: Unravelling a string of folds
33. Thrombospondin 1 as an enzyme inhibitor
34. Catalysis of disulfide isomerization in thrombospondin 1 by protein disulfide isomerase
35. Calcium ion binding to thrombospondin 1
36. Defcient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura
37. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome
38. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura